Aptivus Capsule, Liquid Filled
Product Images NDC 0597-0003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aptivus (NDC 0597-0003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Aptivus 01)

FDA Label Image

Chemical Structure (Aptivus 02)

FDA Label Image

Figure 1 (Aptivus 03)

FDA Label Image

Image (Aptivus 04)

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

Principal Display Panel (250 mg Capsule Bottle Label)
Aptivus is a medication administered in capsule form. The capsules should not be opened or chewed and must be swallowed whole. They contain 250mg of tipranavir and 7% dehydrated alcohol. The drug should be stored in a refrigerator before opening and can be stored at 25°C after opening, but must be used within 60 days. The bottle has a child-resistant closure and should be kept out of reach of children. The prescribing information should be consulted before use. The capsules are distributed by Boehringer Ingelheim Pharmaceuticals Inc. and are licensed from Boehringer Ingelheim International GmbH. An ALERT box should not be covered with a Pharmacy label. Information about medicines that should not be taken with Aptivus is available.*
FDA Label Image

Principal Display Panel (95 mL Bottle Label)

Principal Display Panel (95 mL Bottle Label)
This is a prescription medication called Aptivus, which is an oral solution with a concentration of 100 mg/mL. The package contains 95mL of the medication in a unit of use container. The label contains a warning advising the user to be aware of potential interactions with other medications. The pharmacist is instructed not to cover the alert box with a pharmacy label. The medication should be kept out of reach of children, and the bottle features a child-resistant closure. Store at a temperature between 15°C-25°C, but do not refrigerate or freeze. The medication must be used within 60 days of opening the bottle. This product is distributed by Boehringer Ingelheim Pharmaceuticals, Inc., and the license is from Boehringer Ingelheim International GmbH. The label includes the manufacturer's information, dosage, and other instructions for use.*
FDA Label Image

Principal Display Panel (95 mL Bottle Carton)

Principal Display Panel (95 mL Bottle Carton)
This appears to be an output of a medication label. The medication is Aptivus, available in both an Oral Solution and a Spray Solution, with a 100mg/mL strength. The label includes a warning about the specific medicines that should not be taken with Aptivus and a note to pharmacists about the proper storage instructions. The manufacturer of the medication is Boehringer Ingelheim.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.